The content is available as a PDF (648.2 KB).
. 2022 Jun 16;162(7):S-287. doi: 10.1016/S0016-5085(22)60679-6
Sa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY
Kristin K Joergensen
, Silje W Syversen
, ingrid Jyssum
, Anne Therese Tveter
, Trung T Tran
, Joe Sexton
, Sella A Provan
, Siri Mjaaland
, David J Warren
, Tore K Kvien
, Gunnveig Gr⊘deland
, Lise Sofie H Nissen-Meyer
, Petr Ricanek
, Adity Chopra
, Ane M Anderson
, Grete B Kro
, Ludvig A Munthe
, Espen A Haavardsholm
, John TT Vaage
, Fridtjof Lund-Johansen
, Jorgen Jahnsen
, Guro L Goll
Kristin K Joergensen
Find articles by Kristin K Joergensen
Silje W Syversen
Find articles by Silje W Syversen
ingrid Jyssum
Find articles by ingrid Jyssum
Anne Therese Tveter
Find articles by Anne Therese Tveter
Trung T Tran
Find articles by Trung T Tran
Joe Sexton
Find articles by Joe Sexton
Sella A Provan
Find articles by Sella A Provan
Siri Mjaaland
Find articles by Siri Mjaaland
David J Warren
Find articles by David J Warren
Tore K Kvien
Find articles by Tore K Kvien
Gunnveig Gr⊘deland
Find articles by Gunnveig Gr⊘deland
Lise Sofie H Nissen-Meyer
Find articles by Lise Sofie H Nissen-Meyer
Petr Ricanek
Find articles by Petr Ricanek
Adity Chopra
Find articles by Adity Chopra
Ane M Anderson
Find articles by Ane M Anderson
Grete B Kro
Find articles by Grete B Kro
Ludvig A Munthe
Find articles by Ludvig A Munthe
Espen A Haavardsholm
Find articles by Espen A Haavardsholm
John TT Vaage
Find articles by John TT Vaage
Fridtjof Lund-Johansen
Find articles by Fridtjof Lund-Johansen
Jorgen Jahnsen
Find articles by Jorgen Jahnsen
Guro L Goll
Find articles by Guro L Goll
Issue date 2022 May.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9212477